• Cremer, P., Nagel, D., Labrot, B., Mann, H., Muche, R., Elster, H. & Seidel, C. (1994) Lipoprotein (Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS). European Journal of Clinical Investigation, 24, 444453.
  • Danesh, J., Lewington, S., Thompson, S.G., Lowe, G.D.O. & Collins, R. for the Fibrinogen Studies Collaboration (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and non-vascular mortality: an individual participant meta-analysis. Journal of the American Medical Association, 294, 17991809.
  • Gaffney, P.J. & Wong, M.Y. (1992) Collaborative study of proposed international standard for plasma fibrinogen measurement. Thrombosis and Haemostasis, 68, 428432.
  • Kaptoge, S., Di Angelantonio, E., Lowe, G., Pepys, M.B., Thompson, S.E., Collins, R. & Danesh, J. for the Emerging Risk Factors Collaboration (2010) C-reactive protein concentration and the risk of coronary heart disease, stroke and mortality. Lancet, 375, 132140.
  • Lovely, R.S., Kazmierczak, S.C., Massaro, J.M., D'Agostino, R.B., O'Donnell, C.J. & Farrell, D.H. (2010) γ′ fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease. Clinical Chemistry, 56, 781788.
  • Lowe, G.D.O., Woodward, M., Rumley, A., Morrison, C.E. & Nieuwenhuizen, W. (2003) Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction. Journal of Thrombosis and Haemostasis, 1, 23122316.
  • Lowe, G.D.O., Rumley, A. & Mackie, I. (2004) Analytical review: fibrinogen. Annals of Clinical Biochemistry, 41, 430440.
  • Mackie, I.J., Kitchen, S., Machin, S. & Lowe, G.D.O. (2003) Guidelines on fibrinogen assays. British Journal of Haematology, 121, 396404.
  • Nieuwenhuizen, W. (1995) Biochemistry and measurement of fibrinogen. European Heart Journal, 16, A6A10.
  • Pencina, M.J. & D'Agostino, R.B. (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Statistics in Medicine, 23, 21092123.
  • Pencina, M.J., D'Agostino, Sr, R.B. & Steyerber, E.W. (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Statistics in Medicine, 30, 1121.
  • Rossi, E., Mondonico, P., Lombardi, A. & Preda, L. (1988) Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thrombosis Research, 52, 453468.
  • Rumley, A., Woodward, M., Hoffmeister, A., Koenig, W. & Lowe, G.D.O. (2003) Comparison of plasma fibrinogen by Clauss, prothrombin time-derived, and immunonephelometric assays in a general population; implications for risk stratification by thirds of fibrinogen. Blood Coagulation and Fibrinolysis, 14, 197201.
  • Sweetnam, P.M., Yarnell, J.W.G., Lowe, G.D.O., Baker, I.A., O'Brien, J.R. & Rumley, A. (1998) The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease; the Caerphilly and Speedwell studies. British Journal of Haematology, 100, 582588.
  • Tunstall-Pedoe, H. (ed.) (2003) MONICA Monograph and Multimedia Sourcebook. Geneva, World Health Organization.
  • Tunstall-Pedoe, H. & Woodward, M. for the SIGN group on risk estimation (2006) By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease. Heart, 92, 307310.
  • Tunstall-Pedoe, H., Woodward, M., Tavendale, R., A'Brook, R. & McCluskey, M.K. (1997) Comparison of the prediction by 27 different factors for coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. British Medical Journal, 314, 541546.
  • Von Clauss, A. (1957) Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematologica, 17, 237246.
  • Weinstock, N. & Ntefidou, M. (2006) International Collaborative Study to establish the first high fibrinogen reference material for use with different fibrinogen assay techniques. Journal of Thrombosis and Haemostasis, 4, 18251827.
  • Woodward, M., Lowe, G.D.O., Rumley, A. & Tunstall-Pedoe, H. (1998) Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women: the Scottish Heart Health Study. European Heart Journal, 19, 5562.
  • Woodward, M., Brindle, P. & Tunstall-Pedoe, H. for the SIGN group on risk estimation (2007) Adding social deprivation and family history to cardiovascular risk assessment – the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart, 93, 172176.
  • Woodward, M., Tunstall-Pedoe, H., Rumley, A. & Lowe, G.D.O. (2009) Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Study. British Journal of Haematology, 146, 442446.